The effect of the glycolipoprotein extract (G‐90) from earthworm Eisenia foetida on the wound healing process in alloxan‐induced diabetic rats

Diabetes is now regarded as a major public health problem. The number of patients is estimated to increase to over 439 million cases by 2030. One of the major health clinical problems in patients with diabetes patients is impaired wound healing. Diabetic foot ulcer is a major complication of diabetes mellitus in 12 to 25% of patients, which increases the risk of damage in the limbs or amputation. The earthworm Eisenia foetida glycolipoprotein (as known G‐90) is a blend of macromolecules with some biological properties including mitogenicity, anticoagulation, fibrinolysis, bacteriostatic and antioxidatiaon. Given the biological properties of G‐90, this study was conducted to investigate the effect of extract obtained from the homogenate of Eisenia foetida (G‐90) on the wound healing process in alloxan‐induced diabetic rats. The results of the present study revealed that treatment by using G‐90 can speed up the wound healing process, which is exactly similar to the effect of D‐panthenol treatment in rats. These findings also demonstrated that G‐90 treatment decreases the risk of infection in the wound site compared with D‐panthenol treatment. In addition, histological analysis indicated that a better extracellular matrix formation with increased fibroblast proliferation, neovascularization, collagen synthesis and early epithelial layer formation was observed in G‐90 treated group. Therefore, the G‐90 could be considered as a new wound healing agent introducing promising therapeutic approaches in both human and veterinary medicine. Copyright © 2016 John Wiley & Sons, Ltd.

[1]  J. Shaw,et al.  Global estimates of the prevalence of diabetes for 2010 and 2030. , 2010, Diabetes research and clinical practice.

[2]  M. Grdiša,et al.  Glycolipoprotein extract (G-90) from earthworm Eisenia foetida exerts some antioxidative activity. , 2001, Comparative biochemistry and physiology. Part A, Molecular & integrative physiology.

[3]  S. Pattanayak,et al.  Wound healing, anti-microbial and antioxidant potential of Dendrophthoe falcata (L.f) Ettingsh. , 2008, Journal of ethnopharmacology.

[4]  D. Qujeq,et al.  Relationship between malondialdehyde level and glutathione peroxidase activity in diabetic rats. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[5]  M. Jurin,et al.  Mitogenicity of the earthworm's (Eisenia foetida) insulin-like proteins. , 1993, Comparative biochemistry and physiology. B, Comparative biochemistry.

[6]  D. Graves,et al.  Diabetes prolongs the inflammatory response to a bacterial stimulus through cytokine dysregulation. , 2004, The Journal of investigative dermatology.

[7]  Economic costs of diabetes in the U.S. in 2012. Diabetes Care 2013;36:1033–1046 , 2013, Diabetes Care.

[8]  N. Schaper,et al.  International consensus and practical guidelines on the management and the prevention of the diabetic foot , 2000, Current diabetes reports.

[9]  M. Grdiša,et al.  Stimulation of growth factor synthesis in skin wounds using tissue extract (G‐90) from the earthworm Eissenia foetida , 2004, Cell biochemistry and function.

[10]  H. Kobayashi,et al.  Immunohistochemical localization of endothelin-1 in the nervous system of the earthworm Eisenia foetida. , 1991, General and comparative endocrinology.

[11]  J. Leahy Economic Costs of Diabetes in the U.S. in 2007 , 2008 .

[12]  E. Jude,et al.  Optimal Treatment of Infected Diabetic Foot Ulcers , 2004, Drugs & aging.

[13]  W T Lawrence,et al.  Physiology of the acute wound. , 1998, Clinics in plastic surgery.

[14]  M. Grdiša,et al.  Adhesins of immunoglobulin-like superfamily from earthworm Eisenia foetida. , 1998, General pharmacology.

[15]  L. DiPietro,et al.  Factors Affecting Wound Healing , 2010, Journal of dental research.

[16]  M. Maruyama,et al.  A novel fibrinolytic enzyme extracted from the earthworm, Lumbricus rubellus. , 1991, The Japanese journal of physiology.

[17]  V. Kašuba,et al.  A new source of biologically active compounds--earthworm tissue (Eisenia foetida, Lumbricus rubelus). , 1992, Comparative biochemistry and physiology. Comparative physiology.

[18]  M. Grdiša,et al.  Alternative Sources of Fibrinolytic, Anticoagulative, Antimicrobial and Anticancer Molecules , 2004, International journal of immunopathology and pharmacology.

[19]  N. Schaper,et al.  International consensus and practical guidelines on the management and the prevention of the diabetic foot. International Working Group on the Diabetic Foot. , 2000, Diabetes/metabolism research and reviews.

[20]  M. Grdiša,et al.  Tissue extract from Eisenia foetida as a wound-healing agent. , 2010, European review for medical and pharmacological sciences.

[21]  E. Cooper,et al.  Earthworms: sources of antimicrobial and anticancer molecules. , 2004, Advances in experimental medicine and biology.

[22]  M. Imamura,et al.  Earthworm fibrinolytic enzyme: anti-tumor activity on human hepatoma cells in vitro and in vivo. , 2007, Chinese medical journal.

[23]  M. Grdiša,et al.  Fibrinolytic and anticoagulative activities from the earthworm Eisenia foetida. , 1998, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[24]  J. Pfeilschifter,et al.  Severely impaired insulin signaling in chronic wounds of diabetic ob/ob mice: a potential role of tumor necrosis factor-alpha. , 2006, The American journal of pathology.